| Literature DB >> 35592097 |
Abstract
Purpose: The absence of ionizing radiation in MRI applications does not guarantee absolute safety. Implementing of safety guidelines can ensure high-quality practice in the clinical MRI with the minimum risk. For this purpose, this cross-section quantitative study conducted in Jordan Kingdom aimed to assess current MRI safety guidelines in comparison with those of 2020 Manual on MR Safety of the American College of Radiology (ACR). Patients andEntities:
Keywords: Jordan; ferromagnetic detection; imaging policy; imaging risks; magnetic resonance imaging safety; screening
Year: 2022 PMID: 35592097 PMCID: PMC9113556 DOI: 10.2147/MDER.S360335
Source DB: PubMed Journal: Med Devices (Auckl) ISSN: 1179-1470
Distribution of Healthcare Sectors Participating in the Study
| Site Affiliation | Frequency | Percent |
|---|---|---|
| 4 | 11% | |
| 4 | 11% | |
| 9 | 24% | |
| 10 | 26% | |
| 11 | 29% | |
| 38 | 100% |
Figure 1The availability of MRI safety policies criteria.
Figure 2Frequency of MRI facility safety design elements.
The Distribution of the Available Zone II According to the Facility Affiliation
| Yes % | Count | |
|---|---|---|
| 36% | 4 | |
| 9% | 1 | |
| 18% | 2 | |
| 18% | 2 | |
| 18% | 2 | |
| 100% | 11 |
Figure 3Frequency of preliminary MRI clinical screening methods.
Figure 4Availability of physical screening methods.
Figure 5Count distributions of MR-compatible equipment.
Figure 6The level of emergency preparedness action.
The Availability of ACR Recommended MRI Zones and Their Signages
| Zone No. | Available | Demarcated and Labelled | ||
|---|---|---|---|---|
| Yes | % | Yes | No | |
| 38 | 100 | 0 | 38 | |
| 11 | 29 | 0 | 38 | |
| 38 | 100 | 0 | 38 | |
| 38 | 100 | 0 | 38 | |
Abbreviations: MRI, Magnetic Resonance Imaging; ACR, American College of Radiology; SPSS, Statistical Package for the Social Sciences; CT, computed tomography; RF, radiofrequency; SAR, specific absorption rate; RANZCR, Royal Australia/New Zealand College of Radiology; IRB, Institutional Review Board; MHRA, Medicines and Healthcare Products Regulatory Agency; FDS, Ferromagnetic Detection System; MoH, Ministry of Health.